• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Director Van Wyk Steven C. was granted 45,576 shares (SEC Form 4)

    5/23/25 4:24:22 PM ET
    $GNW
    Life Insurance
    Finance
    Get the next $GNW alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Van Wyk Steven C.

    (Last) (First) (Middle)
    C/O GENWORTH FINANCIAL, INC.
    11011 WEST BROAD STREET

    (Street)
    GLEN ALLEN VA 23060

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    GENWORTH FINANCIAL INC [ GNW ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/21/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/21/2025 A 3,954.067(1) A $6.67(2) 3,954.067 D
    Common Stock 05/22/2025 A 41,621.816(3) A $6.9675(4) 45,575.883 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Reflects award of restricted stock units (RSUs) in payment of a portion of the reporting person's annual retainer fee for 2024-2025 service year. This award is pro-rated from March 19, 2025, the date the reporting person was elected as a Director, through the date of the 2025 Annual Meeting of Stockholders. The RSUs vest on the one-year anniversary of the grant date, and convert to shares of Common Stock upon vesting (unless the reporting person elected to defer receipt of the shares until termination of service as a director or to a future specified year).
    2. Reflects the twenty-day average trading price per share of Common Stock as of March 19, 2025, which was used to determine the number of RSUs granted.
    3. Reflects award of RSUs in payment of a portion of the reporting person's annual retainer fee. The RSUs vest on the one-year anniversary of the grant date, and convert to shares of Common Stock upon vesting (unless the reporting person elected to defer receipt of the shares until termination of service as a director or to a future specified year).
    4. Reflects the twenty-day average trading price per share of Common Stock, which was used to determine the number of RSUs granted.
    /s/ David F. Kurzawa, by power of attorney 05/23/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GNW alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GNW

    DatePrice TargetRatingAnalyst
    6/18/2025$9.00Mkt Perform → Outperform
    Keefe Bruyette
    More analyst ratings

    $GNW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Genworth Financial upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Genworth Financial from Mkt Perform to Outperform and set a new price target of $9.00

    6/18/25 7:44:47 AM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CareScout Launches Care Assurance, First Insurance Solution for Company

    Inaugural long-term care insurance product will help families plan, find, and fund care with confidence CareScout today announced the launch of CareScout Care Assurance, its insurance company's first long-term care (LTC) insurance solution. This represents a milestone in CareScout's mission to simplify and dignify the aging journey and signals the start of a broader portfolio of funding solutions and services designed to support families. "The launch of CareScout Care Assurance is more than the introduction of a product, it's the beginning of a new chapter for CareScout, as we provide curated experiences for our long-term care insurance policyholders based on their needs and preferences

    10/1/25 9:00:00 AM ET
    $GNW
    Life Insurance
    Finance

    Genworth Financial Announces New $350 Million Share Repurchase Authorization

    Genworth Financial, Inc. (NYSE:GNW) today announced that its Board of Directors has authorized a new share repurchase program under which Genworth may repurchase up to $350 million of its outstanding common stock. The new share repurchase authorization is in addition to Genworth's current $700 million share repurchase program, of which $16 million remains as of September 17, 2025. "The Board's decision to authorize a new share repurchase program reflects the company's commitment to delivering shareholder returns," said Tom McInerney, Genworth's President and Chief Executive Officer. "Supported by strong cash flows from our subsidiary, Enact Holdings, Inc., we are very pleased with our pro

    9/18/25 4:16:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    AM Best Revises Outlooks to Positive for Enact Holdings, Inc. and Certain Operating Subsidiaries

    AM Best has revised the outlooks to positive from stable and affirmed the Financial Strength Rating (FSR) of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a-" (Excellent) of the following operating subsidiaries of Enact Holdings, Inc. (EHI) (Delaware) (NASDAQ:ACT): Enact Mortgage Insurance Corporation (EMIC) and Enact Mortgage Insurance Corporation of North Carolina (EMIC-NC) (collectively referred to as the Enact U.S.-domiciled companies). Both operating companies are domiciled in Raleigh, N.C. AM Best also has revised the outlook to positive from stable and affirmed the Long-Term ICR of "bbb-" (Good) of EHI. In addition, AM Best has affirmed the FSR of A- (Exc

    9/18/25 10:07:00 AM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    $GNW
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Genworth Financial Inc

    SCHEDULE 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    8/15/25 8:10:13 AM ET
    $GNW
    Life Insurance
    Finance

    SEC Form 10-Q filed by Genworth Financial Inc

    10-Q - GENWORTH FINANCIAL INC (0001276520) (Filer)

    7/31/25 4:37:44 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form 8-K filed by Genworth Financial Inc

    8-K - GENWORTH FINANCIAL INC (0001276520) (Filer)

    7/30/25 4:13:41 PM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO, Enact Gupta Rohit sold $749,866 worth of shares (86,406 units at $8.68), decreasing direct ownership by 10% to 794,630 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    8/29/25 4:16:04 PM ET
    $GNW
    Life Insurance
    Finance

    Pres. & CEO, CareScout Svcs. Shah Samir B. converted options into 15,964 shares and covered exercise/tax liability with 8,160 shares, increasing direct ownership by 20% to 46,458 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    7/14/25 4:16:50 PM ET
    $GNW
    Life Insurance
    Finance

    President and CEO; Director Mcinerney Thomas J gifted 150,000 shares, decreasing direct ownership by 3% to 4,727,910 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    5/28/25 4:18:26 PM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Leadership Updates

    Live Leadership Updates

    View All

    CareScout, a Genworth Company, Aims to Redefine Quality and Build Trust in Long-Term Care

    CareScout Quality Network brings together providers committed to person-centered care. CareScout today introduced the CareScout Quality Network, a first-of-its-kind group of long-term care providers who meet high standards for quality, person-centered care. "The long-term care industry is ripe for innovation because health and social systems aren't built to support the demand of our rapidly aging population. Older adults and their families are left to navigate a fragmented and confusing experience to find care," said Samir Shah, CEO of CareScout Services. "Quality measures today only meet the lowest common denominator of patient safety, which is important, but provides zero insight into

    2/13/24 8:30:00 AM ET
    $GNW
    Life Insurance
    Finance

    Genworth And Oceanwide Provide Transaction Update; Genworth To Focus on Contingency Plan

    RICHMOND, Va., Jan. 4, 2021 /PRNewswire/ -- Genworth Financial, Inc. (NYSE: GNW) (Genworth, the Company) and China Oceanwide Holdings Group Co., Ltd. (Oceanwide) today provided an update on their pending transaction. Given uncertainty around the completion and timing of the remaining steps required to close the transaction, Genworth and Oceanwide have not extended the current December 31, 2020 "end date" under the merger agreement. Oceanwide has indicated that the factors contributing to the delay since the parties agreed to their most recent extension of the merger agreement on November 30, 2020 were: (a) the finalization of the Hony Capital financing terms; and (b) the COVID-19 pandemi

    1/4/21 7:00:00 AM ET
    $GNW
    Life Insurance
    Finance

    $GNW
    Financials

    Live finance-specific insights

    View All

    Genworth Financial Announces Second Quarter 2025 Results

    Strategic Highlights Favorable ruling for AXA in the UK Payment Protection Insurance Case; Genworth to share in funds that AXA recovers Delivered 804 matches1 with providers in the CareScout Quality Network in the quarter with over 90% home care coverage of the aged 65-plus census population in the United States Launched Care Plans, a fee-based service helping consumers evaluate long-term care needs and find caregivers, growing the CareScout product suite Repurchased $30M shares in the quarter; $620M since program inception Continued progress on the LTC2 multi-year rate action plan with $41M of gross incremental premium approvals; approximately $31.6B estimated net present va

    7/30/25 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Genworth Financial Schedules Earnings Conference Call for July 31

    Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing second quarter results after the market closes on July 30, 2025. A conference call will be held on July 31, 2025, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's July 31 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #8808137. To participate in the cal

    7/10/25 4:15:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Genworth Financial Announces First Quarter 2025 Results

    Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

    4/30/25 4:15:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    $GNW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Genworth Financial Inc

    SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    10/25/24 3:16:06 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SC 13G/A filed by Genworth Financial Inc (Amendment)

    SC 13G/A - GENWORTH FINANCIAL INC (0001276520) (Subject)

    2/13/24 5:06:12 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SC 13G filed by Genworth Financial Inc

    SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    2/9/24 9:59:00 AM ET
    $GNW
    Life Insurance
    Finance